Show simple item record

dc.contributor.authorSandhu, U
dc.contributor.authorCebula, M
dc.contributor.authorBehme, S
dc.contributor.authorRiemer, P
dc.contributor.authorWodarczyk, C
dc.contributor.authorMetzger, D
dc.contributor.authorReimann, J
dc.contributor.authorSchirmbeck, R
dc.contributor.authorHauser, H
dc.contributor.authorWirth, D
dc.date.accessioned2011-02-04T15:20:33Z
dc.date.available2011-02-04T15:20:33Z
dc.date.issued2011-01-01
dc.identifier.citationStrict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. 2011, 39 (1):e1 Nucleic Acids Res.en
dc.identifier.issn1362-4962
dc.identifier.pmid20935052
dc.identifier.doi10.1093/nar/gkq868
dc.identifier.urihttp://hdl.handle.net/10033/121272
dc.description.abstractRecombinant mouse strains that harbor tightly controlled transgene expression proved to be indispensible tools to elucidate gene function. Different strategies have been employed to achieve controlled induction of the transgene. However, many models are accompanied by a considerable level of basal expression in the non-induced state. Thereby, applications that request tight control of transgene expression, such as the expression of toxic genes and the investigation of immune response to neo antigens are excluded. We developed a new Cre/loxP-based strategy to achieve strict control of transgene expression. This strategy was combined with RMCE (recombinase mediated cassette exchange) that facilitates the targeting of genes into a tagged site in ES cells. The tightness of regulation was confirmed using luciferase as a reporter. The transgene was induced upon breeding these mice to effector animals harboring either the ubiquitous (ROSA26) or liver-specific (Albumin) expression of CreER(T2), and subsequent feeding with Tamoxifen. Making use of RMCE, luciferase was replaced by Ovalbumin antigen. Mice generated from these ES cells were mated with mice expressing liver-specific CreER(T2). The transgenic mice were examined for the establishment of an immune response. They were fully competent to establish an immune response upon hepatocyte specific OVA antigen expression as indicated by a massive liver damage upon Tamoxifen treatment and did not show OVA tolerance. Together, this proves that this strategy supports strict control of transgenes that is even compatible with highly sensitive biological readouts.
dc.language.isoenen
dc.titleStrict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for Infection Research, D-38124 Braunschweig, Germany.en
dc.identifier.journalNucleic acids researchen
refterms.dateFOA2018-06-13T05:26:21Z
html.description.abstractRecombinant mouse strains that harbor tightly controlled transgene expression proved to be indispensible tools to elucidate gene function. Different strategies have been employed to achieve controlled induction of the transgene. However, many models are accompanied by a considerable level of basal expression in the non-induced state. Thereby, applications that request tight control of transgene expression, such as the expression of toxic genes and the investigation of immune response to neo antigens are excluded. We developed a new Cre/loxP-based strategy to achieve strict control of transgene expression. This strategy was combined with RMCE (recombinase mediated cassette exchange) that facilitates the targeting of genes into a tagged site in ES cells. The tightness of regulation was confirmed using luciferase as a reporter. The transgene was induced upon breeding these mice to effector animals harboring either the ubiquitous (ROSA26) or liver-specific (Albumin) expression of CreER(T2), and subsequent feeding with Tamoxifen. Making use of RMCE, luciferase was replaced by Ovalbumin antigen. Mice generated from these ES cells were mated with mice expressing liver-specific CreER(T2). The transgenic mice were examined for the establishment of an immune response. They were fully competent to establish an immune response upon hepatocyte specific OVA antigen expression as indicated by a massive liver damage upon Tamoxifen treatment and did not show OVA tolerance. Together, this proves that this strategy supports strict control of transgenes that is even compatible with highly sensitive biological readouts.


Files in this item

Thumbnail
Name:
Sandhu et al_final.pdf
Size:
6.655Mb
Format:
PDF
Description:
Open Access publication
Thumbnail
Name:
Supplementary_Sandhu.ppt
Size:
203.5Kb
Format:
Microsoft PowerPoint
Description:
supplemental figure

This item appears in the following Collection(s)

Show simple item record